> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Corrects Xenpozyme Patent Notice
- URL: https://www.fdaweb.com/fda-corrects-xenpozyme-patent-notice/
- Published: 2024-07-22T12:00:00.000Z
- Updated: 2026-09-14T14:36:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157396

*Federal Register* notice: FDA is correcting a 7/2 notice that announced the determination of the regulatory review period for Sanofi’s Xenpozyme (olipudase alfa-rpcp) for patent extension purposes. The document was published with an incorrect patent number, and this notice corrects that. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-07-22/pdf/2024-15998.pdf?ref=fdaweb.com).